OPKO Health, Inc.OPKNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.96% | -13.66% | -13.93% | -12.65% | -19.13% |
| Gross Profit Growth | +89.36% | +1.31% | -4.36% | +77.59% | +4.54% |
| EBITDA Growth | +0.00% | +0.00% | -417.99% | -16.02% | -127.90% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +238.04% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -13.09% | -323.14% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -22.35% | -301.98% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -7.67% | -301.98% |
| Weighted Average Shares Growth | +6.11% | -4.99% | -3.68% | +11.88% | -4.00% |
| Weighted Average Shares Diluted Growth | -7.65% | -4.99% | -3.68% | +12.12% | +10.30% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +16.78% | +7.98% | +16.00% | -10.30% | -40.64% |
| Inventory Growth | -13.55% | +7.81% | +10.29% | +9.34% | +15.89% |
| Asset Growth | +9.37% | +7.82% | -0.35% | -11.55% | -12.19% |
| Book Value per Share Growth | -7.37% | +10.20% | -3.51% | -16.86% | -3.27% |
| Debt Growth | +54.47% | +17.47% | +46.87% | -22.82% | -14.04% |
| R&D Expense Growth | +56.83% | +40.59% | +25.99% | +4.55% | +7.81% |
| SG&A Expenses Growth | -8.05% | -15.79% | -13.40% | -45.21% | -24.66% |